EVGN Insider Trading Activity and SEC Form 4 Filings
EVGN insider trading summary
Over the past 12 months, insiders at Evogene Ltd. (EVGN) reported 3 open-market purchases worth $693K by 2 insiders and no sales on SEC Form 4. Net insider buying was $693K.
Latest EVGN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 11, 2026 | Leon Recanati | Director | Buy | $292K (460,000 @ $0.64) |
| Aug 4, 2026 | Leon Recanati | Director | Buy | $400K (800,000 @ $0.50) |
| Jun 4, 2026 | Gabi Tarcic | Chief Development Officer | Buy | $677 (1,129 @ $0.60) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.